CAPTRUST Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.14M | Sell |
12,503
-752
| -6% | -$256K | 0.01% | 846 |
|
|
2025
Q4 | $5.27M | Buy |
13,255
+5,586
| +73% | +$2.47M | 0.01% | 652 |
|
|
2025
Q3 | $3.5M | Buy |
7,669
+4,163
| +119% | +$1.7M | 0.01% | 775 |
|
|
2025
Q2 | $1.14M | Sell |
3,506
-2,875
| -45% | -$796K | ﹤0.01% | 1274 |
|
|
2025
Q1 | $1.72M | Sell |
6,381
-33
| -0.5% | -$8.48K | ﹤0.01% | 973 |
|
|
2024
Q4 | $1.51M | Buy |
6,414
+1,581
| +33% | +$416K | ﹤0.01% | 1016 |
|
|
2024
Q3 | $1.33M | Buy |
4,833
+1,237
| +34% | +$322K | ﹤0.01% | 1028 |
|
|
2024
Q2 | $874K | Sell |
3,596
-43
| -1% | -$6.79K | ﹤0.01% | 1215 |
|
|
2024
Q1 | $544K | Sell |
3,639
-975
| -21% | -$163K | ﹤0.01% | 1439 |
|
|
2023
Q4 | $883K | Buy |
4,614
+427
| +10% | +$72.7K | ﹤0.01% | 1352 |
|
|
2023
Q3 | $742K | Sell |
4,187
-734
| -15% | -$140K | ﹤0.01% | 1388 |
|
|
2023
Q2 | $935K | Buy |
4,921
+2,736
| +125% | +$542K | ﹤0.01% | 1248 |
|
|
2023
Q1 | $438K | Buy |
2,185
+570
| +35% | +$120K | ﹤0.01% | 1473 |
|
|
2022
Q4 | $384K | Buy |
1,615
+140
| +9% | +$29.9K | ﹤0.01% | 1477 |
|
|
2022
Q3 | $295K | Buy |
1,475
+190
| +15% | +$36.2K | ﹤0.01% | 1551 |
|
|
2022
Q2 | $187K | Buy |
1,285
+53
| +4% | +$7.52K | ﹤0.01% | 1739 |
|
|
2022
Q1 | $201K | Buy |
1,232
+329
| +36% | +$50.1K | ﹤0.01% | 1721 |
|
|
2021
Q4 | $153K | Buy |
903
+50
| +6% | +$9.29K | ﹤0.01% | 1832 |
|
|
2021
Q3 | $161K | Buy |
853
+151
| +22% | +$28.3K | ﹤0.01% | 1721 |
|
|
2021
Q2 | $119K | Buy |
702
+36
| +5% | +$5.27K | ﹤0.01% | 1886 |
|
|
2021
Q1 | $94K | Buy |
666
+503
| +309% | +$75.7K | ﹤0.01% | 1999 |
|
|
2020
Q4 | $21K | Sell |
163
-60
| -27% | -$8.01K | ﹤0.01% | 2222 |
|
|
2020
Q3 | $32K | Hold |
223
| – | – | ﹤0.01% | 1774 |
|
|
2020
Q2 | $33K | Buy |
+223
| New | +$30.1K | ﹤0.01% | 1768 |
|
|
2019
Q4 | – | Sell |
-883
| Closed | -$71K | – | 1029 |
|
|
2019
Q3 | $71K | Buy |
883
+733
| +489% | +$58K | ﹤0.01% | 883 |
|
|
2019
Q2 | $11K | Hold |
150
| – | – | ﹤0.01% | 1462 |
|
|
2019
Q1 | $14K | Hold |
150
| – | – | ﹤0.01% | 1282 |
|
|
2018
Q4 | $11K | Hold |
150
| – | – | ﹤0.01% | 1191 |
|
|
2018
Q3 | $13K | Hold |
150
| – | – | ﹤0.01% | 1147 |
|
|
2018
Q2 | $15K | Hold |
150
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q1 | $15K | Hold |
150
| – | – | ﹤0.01% | 917 |
|
|
2017
Q4 | $19K | Hold |
150
| – | – | ﹤0.01% | 794 |
|
|
2017
Q3 | $18K | Buy |
+150
| New | +$12.8K | ﹤0.01% | 371 |
|
Other funds holding ALNY
VPM
VCM
